Adjuvant intra-articular vancomycin for recalcitrant Staphylococcal prosthetic joint infections of the knee.
James B DoubEmily L HeilTheodore MansonPublished in: European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2023)
The aggressive protocol used in this cohort with repeat two-stage revision surgery, intra-articular vancomycin and systemic antibiotics was able to prevent recurrence of infection in most patients, but higher than expected rates of acute kidney injury were observed in this study. Therefore, while intra-articular vancomycin therapy may have some effectiveness in treating recalcitrant prosthetic joint infections, its ability to eradicate all bacterial niduses is unproven, and clinicians should be cognizant of potential adverse events that can occur with this therapy.
Keyphrases
- methicillin resistant staphylococcus aureus
- acute kidney injury
- total knee arthroplasty
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- minimally invasive
- staphylococcus aureus
- newly diagnosed
- systematic review
- early stage
- peritoneal dialysis
- prognostic factors
- palliative care
- coronary artery bypass
- stem cells
- knee osteoarthritis
- acute coronary syndrome
- total hip arthroplasty
- risk assessment
- percutaneous coronary intervention
- climate change
- cell therapy
- atrial fibrillation